LAB7 Backs Homeostasis to Advance CO2 Conversion Into Synthetic Graphite

LAB7, the venture building arm of Aramco, has announced a strategic partnership and investment in Homeostasis to advance carbon dioxide (CO₂) conversion into synthetic graphite for industrial applications. This collaboration supports the development of new manufacturing processes that transform captured CO₂ emissions into high-value graphite. Homeostasis is developing a new innovative technology to convert carbon dioxide (CO₂) into synthetic graphite for industrial applications. This partnership represents a significant step towards advancing sustainable manufacturing practices while supporting global carbon emissions reduction efforts and reinforces LAB7’s role as a strategic partner for startups advancing disruptive technological solutions.

>> In Other News: Online Hub Centralizes Data to Empower Carbon Storage Projects

The global shift toward electrification has created an urgent need for critical materials, particularly graphite, which functions as the anode in lithium-ion batteries. Homeostasis is addressing this challenge by transforming CO₂ emissions into high-value synthetic graphite, enabling lower carbon materials for the energy storage industry, with a focus on electric vehicles battery solutions.

“Homeostasis welcomes LAB7’s support as we unlock the CO₂-to-graphite vertical, a new technology for the growing graphite market,” said Makoto Eyre, Co-Founder and CEO. “Homeostasis will deliver the ability to produce graphite from the growing global fleet of CO₂ capture assets.”

Through this partnership and investment, LAB7 will help Homeostasis improve its production process and scale operations effectively, supporting market readiness.

“This partnership is a key step in harnessing the strategic advantages of the circular economy,” said Dr. Julien Lombardi, Co-Founder and Chief Science Officer. “Our technology strengthens energy infrastructure by transforming waste streams into a widely available feedstock.”

By combining transformative concepts with actionable solutions, LAB7 and Homeostasis aim to reshape how industries view carbon emissions; not as waste, but as a resource for building a more sustainable future.

About Homeostasis

Homeostasis develops molten salt electrolysis technology to convert CO₂ emissions into high-value carbon materials foundational to today’s economy. Our process consumes carbon dioxide from industrial waste streams using only electricity. Today, our focus is on producing high-purity anode-grade graphite for lithium-ion batteries. We source CO₂ from captured industrial waste streams at chemical plants, refineries, and manufacturing facilities. This approach will unlock tens of millions of tons of low-cost feedstock available in all industrialized nations – which represents a fundamental shift in how critical materials for batteries are sourced today. For more information: www.homeostasis.earth

About LAB7

LAB7 is a venture builder backed by Aramco, operating within an Aramco subsidiary. Dedicated to pushing the boundaries of technology, LAB7 provides a system of support, collaboration, and expertise for accelerated product launch and market access.

If you want this styled further for SEO or publication on Decarbonfuse.com (headlines, subheads, meta descriptions), tell me and I’ll tailor it. (LAB7)